Researchers from City St George’s, University of London are calling for more research to confirm whether the increase in ...

Grant documents that detailed creating the virus that causes COVID-19 may have been concealed, leading to a "flawed" probe of ...

Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets ...

We tend to think of COVID-19 as a respiratory illness. But, like many viruses, COVID can also affect your skin and cause ...

"Very high" levels of the virus were detected by the CDC in New Mexico, with "high" levels in Oregon, Arkansas, and Maine.

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

XWELL delivered 2024 third quarter revenue growth of approximately 13% from the comparable quarter in 2023. Additionally, for the nine-month period ended September 30, 2024, XWELL delivered revenue ...

The manuscript was released online ahead of publication in The Journal of Molecular Diagnostics. AMP convened a SARS-CoV-2 Whole Genome Sequencing Working Group with organizational representation from ...

State Public Health Lab found Influenza A and B viruses circulating in Tamil Nadu, causing mild illness in patients.

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, ...